These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22308258)

  • 1. [Anxiety disorder].
    Inoue T; Koyama T
    Brain Nerve; 2012 Feb; 64(2):131-8. PubMed ID: 22308258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobiology of anxiety disorders and implications for treatment.
    Garakani A; Mathew SJ; Charney DS
    Mt Sinai J Med; 2006 Nov; 73(7):941-9. PubMed ID: 17195879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of midazolam and D-cycloserine on the release of glutamate and GABA in the basolateral amygdala of low and high anxiety rats during extinction trial of a conditioned fear test.
    Lehner M; Wisłowska-Stanek A; Taracha E; Maciejak P; Szyndler J; Skórzewska A; Turzyńska D; Sobolewska A; Hamed A; Bidziński A; Płaźnik A
    Neurobiol Learn Mem; 2010 Nov; 94(4):468-80. PubMed ID: 20807585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroimaging and pathology in anxiety disorders, especially stress-induced fear circuitry disorders].
    Shioiri T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Jun; 30(3):135-9. PubMed ID: 20666145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extending animal models of fear conditioning to humans.
    Delgado MR; Olsson A; Phelps EA
    Biol Psychol; 2006 Jul; 73(1):39-48. PubMed ID: 16472906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy in rodent amygdala against fear disorders.
    Mitra R; Sapolsky RM
    Expert Opin Biol Ther; 2010 Sep; 10(9):1289-303. PubMed ID: 20662544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fear extinction in rats: implications for human brain imaging and anxiety disorders.
    Milad MR; Rauch SL; Pitman RK; Quirk GJ
    Biol Psychol; 2006 Jul; 73(1):61-71. PubMed ID: 16476517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extinction deficit and fear reinstatement after electrical stimulation of the amygdala: implications for kindling-associated fear and anxiety.
    Kellett J; Kokkinidis L
    Neuroscience; 2004; 127(2):277-87. PubMed ID: 15262319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single prolonged stress: toward an animal model of posttraumatic stress disorder.
    Yamamoto S; Morinobu S; Takei S; Fuchikami M; Matsuki A; Yamawaki S; Liberzon I
    Depress Anxiety; 2009; 26(12):1110-7. PubMed ID: 19918929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA receptors and fear extinction: implications for cognitive behavioral therapy.
    Davis M
    Dialogues Clin Neurosci; 2011; 13(4):463-74. PubMed ID: 22275851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics.
    Mathew SJ; Price RB; Charney DS
    Am J Med Genet C Semin Med Genet; 2008 May; 148C(2):89-98. PubMed ID: 18412102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitation of conditioned fear extinction by d-cycloserine is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase cascades and requires de novo protein synthesis in basolateral nucleus of amygdala.
    Yang YL; Lu KT
    Neuroscience; 2005; 134(1):247-60. PubMed ID: 15951121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the density of GABA-A receptor alpha-2 subunits and gephyrin in brain structures of rats selected for low and high anxiety in basal and fear-stimulated conditions, in a model of contextual fear conditioning.
    Lehner M; Wisłowska-Stanek A; Skórzewska A; Maciejak P; Szyndler J; Turzyńska D; Sobolewska A; Płaźnik A
    Neurobiol Learn Mem; 2010 Nov; 94(4):499-508. PubMed ID: 20833253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural correlates of perception of emotional facial expressions in out-patients with mild-to-moderate depression and anxiety. A multicenter fMRI study.
    Demenescu LR; Renken R; Kortekaas R; van Tol MJ; Marsman JB; van Buchem MA; van der Wee NJ; Veltman DJ; den Boer JA; Aleman A
    Psychol Med; 2011 Nov; 41(11):2253-64. PubMed ID: 21557888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ethanol withdrawal on fear memory: Effect of D-cycloserine.
    Bertotto ME; Bustos SG; Molina VA; Martijena ID
    Neuroscience; 2006 Nov; 142(4):979-90. PubMed ID: 16934411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extinction of emotional response as a novel approach of pharmacotherapy of anxiety disorders].
    Lehner M; Wisłowska-Stanek A; Płaznik A
    Psychiatr Pol; 2009; 43(6):639-53. PubMed ID: 20209877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale.
    Johansen PØ; Krebs TS
    J Psychopharmacol; 2009 Jun; 23(4):389-91. PubMed ID: 19273493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amygdaloid lesions produced similar contextual fear conditioning disruption in the Carioca high- and low-conditioned freezing rats.
    de Castro Gomes V; Landeira-Fernandez J
    Brain Res; 2008 Oct; 1233():137-45. PubMed ID: 18691560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological basis of anxiety disorders and serotonergic anxiolytics].
    Inoue T; Izumi T; Li XB; Huang JZ; Kitaichi Y; Nakagawa S; Koyama T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun; 24(3):125-31. PubMed ID: 15291241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder.
    Lonsdorf TB; Weike AI; Nikamo P; Schalling M; Hamm AO; Ohman A
    Psychol Sci; 2009 Feb; 20(2):198-206. PubMed ID: 19175757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.